MK0476 Phase III Long-term Study -Perennial Allergic Rhinitis.

Trial Profile

MK0476 Phase III Long-term Study -Perennial Allergic Rhinitis.

Phase of Trial: Phase III

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Perennial allergic rhinitis
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 14 Mar 2013 Actual end date changed from Aug 2005 to Feb 2005 as reported by
    • 25 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top